Increase in activity of Na(+), K(+)-ATPase by Porphyrin compounds as treatment for Dysnatremias caused by Diabetes Mellitus.

OBJECTIVE: The aim of this study was to test the action of Porphyrin compounds, Tetraphenylporphine sulfonate (TPPS), 5,10,15,20-Tetrakis (4-sulfonatophenyl) porphyrinato Iron(III) Chloride (FeTPPS) and 5,10,15,20-Tetrakis (4-sulfonatophenyl) porphyrinato Iron(III) nitrosyl Chloride (FeNOTPPS), on Na+, K+ -ATPase of cell membrane of erythrocytes.

METHODS: Enzymatic assays, measuring the amount of inorganic phosphate produced, were used to estimate the activity of Na(+), K(+)-ATPase.

RESULTS: The results show that Porphyrin compounds exert an insulin-like effect on Na(+), K(+)-ATPase. They act by increasing the activity of the membrane-bound enzyme.

CONCLUSION: All the three Porphyrin compounds increased the activity of erythrocyte Na(+), K(+)-ATPase. The exact mechanism of action of these compounds is not clear.